Metformin is one of the most widely prescribed medications for managing type 2 diabetes and related metabolic conditions. While many people take it safely and effectively, it is important to understand the potential health risks that can come with its use. Like any medication, metformin carries both common and rare side effects that deserve attention, especially for those considering or already using the drug.
The good news is that most side effects of metformin are mild and manageable. Many people tolerate the medication well, and serious complications are uncommon when the drug is used appropriately. However, understanding what risks exist, who is most vulnerable, and what warning signs to watch for empowers you to make informed decisions about your treatment and to communicate effectively with your healthcare provider.
This guide walks through the main health risks associated with metformin, from everyday gastrointestinal upset to rare but serious conditions, and explains what factors increase your vulnerability to these risks.
Metformin commonly causes side effects like nausea, diarrhea and bloating. These digestive complaints are by far the most frequent adverse effects people experience when starting the medication, though they tend to improve over time.
Diarrhea is the most common side effect of metformin, and in a placebo-controlled study of immediate-release tablets, 53% of people had diarrhea, compared with 12% of people taking a placebo. The severity varies depending on which form of metformin you take—extended-release versions typically cause fewer and milder digestive symptoms than immediate-release forms. It is usually worse in the first weeks and after a dose increase, and it gets better for most people.
Other gastrointestinal complaints include vomiting, wind (flatulence), indigestion, and headache. Gastrointestinal symptoms are usually time limited, and in one study, most GI symptoms resolved completely within the first week of treatment.
If gastrointestinal side effects are severe or persistent, talk with your healthcare provider. They may recommend adjusting your dose, switching to a different formulation, or temporarily pausing the medication until symptoms settle.
One of the less widely recognized risks of long-term metformin use is vitamin B12 deficiency. Metformin can lower your vitamin B12 levels over time. This is a real concern for people taking the drug for extended periods, yet it often goes undetected.
Vitamin B12 acts as a cofactor for enzymes essential for DNA synthesis and neuroprotection, and vitamin B12 deficiency can show clinical effects such as progressive demyelination, peripheral neuropathy and haematological abnormalities such as macrocytic anaemia.
The mechanism is not fully understood, but metformin, a biguanide medication, has a hydrophobic tail that embeds into the hydrocarbon core of membranes, while the positively charged end alters the surface charge of the cell membrane. This alteration disrupts the function of divalent cations, such as calcium. A consequence of metformin's action on membranes is its potential to act as a calcium channel blocker. This disruption can interfere with the intestinal absorption of vitamin B12.
Clinical manifestations of VB12 deficiency include anemia, peripheral neuropathy, cognitive impairment, and depression. Symptoms may develop slowly and include fatigue, weakness, numbness or tingling in the hands and feet, memory problems, mood changes, and loss of appetite. These changes are usually permanent due to the irreversible nature of demyelination and nerve degeneration.
Because vitamin B12 deficiency can mimic or worsen nerve damage from diabetes itself, it is easy to miss. Regular monitoring through blood tests is recommended for people on long-term metformin therapy, particularly those taking higher doses or using the medication for many years.
The most serious potential complication of metformin is lactic acidosis, a buildup of lactic acid in the blood that can cause severe illness or death. However, it is crucial to understand that this condition is extremely rare.
Lactic acidosis is a buildup of acid in the blood. It is the most serious risk with metformin, and it can be fatal. That said, a large review that pooled 347 studies found no cases at all across more than 70,000 patient-years of metformin use, and estimated the true rate at no more than about 4 cases per 100,000 patient-years.
Almost everyone who develops it has another serious problem going on at the same time, such as kidney failure, a heart attack, a severe infection, or heavy alcohol use. It's more likely to occur if there are super high levels of metformin in the bloodstream and someone has reduced kidney function where it's not being cleared out.
| Risk Factor | Why It Matters |
|---|---|
| Kidney disease or impaired renal function | Reduces the body's ability to clear metformin, allowing it to accumulate to dangerous levels |
| Advanced age (over 65) | Age-related changes in kidney and liver function increase vulnerability |
| Severe dehydration | Dehydration concentrates metformin in the blood and reduces kidney filtration |
| Heart failure or respiratory disease | These conditions reduce oxygen availability, a key factor in lactic acidosis risk |
| Liver disease | Impairs the body's ability to clear and process lactic acid |
| Heavy alcohol consumption | Alcohol interferes with lactate metabolism and increases acidosis risk |
| Acute illness or infection | Metabolic stress and reduced oxygen can trigger or worsen the condition |
If you take metformin, you should know the warning signs of lactic acidosis and seek immediate medical attention if they appear. These include severe fatigue, unusual weakness, difficulty breathing, muscle pain, dizziness, rapid or irregular heartbeat, severe nausea or vomiting, abdominal pain, or feeling unusually cold. Patients and their families should be educated about the symptoms of lactic acidosis and, if these symptoms occur, they should be instructed to discontinue metformin and contact their health care provider.
In an emergency, call local emergency services or go to the nearest emergency room immediately.
Metformin doesn't usually cause hypoglycemia on its own unless it's taken in combination with insulin or other diabetes medications like sulfonylureas, which also raise your risk for hypoglycemia. This is an important distinction: metformin alone is generally safe from low blood sugar, but when combined with certain other drugs, the risk changes.
Hypoglycemia, or low blood sugar, can also be life-threatening if left untreated. If you are taking metformin with other diabetes medications, you should monitor your blood sugar levels regularly and learn to recognize the signs of dangerously low blood sugar: shakiness, sweating, rapid heartbeat, confusion, anxiety, or difficulty concentrating.
Because of this, if you have kidney disease or other kidney conditions, notify your healthcare provider before taking metformin. Kidney function is critical to how your body handles metformin, since metformin is cleared by the kidneys and it has historically been contraindicated in patients with chronic kidney disease (CKD) because of concerns of lactic acidosis with drug accumulation.
Modern understanding has evolved somewhat, and metformin use has been shown to be associated with reduced rates of mortality, cardiovascular disease and progression to end-stage renal disease (ESRD) in T2D patients with chronic kidney disease (CKD). Still, metformin should be administered with caution to patients with CKD because it may increase the risk of lactic acidosis.
Your healthcare provider will assess your kidney function through blood tests (measuring creatinine and eGFR) and determine whether metformin is safe for you and at what dose. All patients treated with metformin should have renal function monitored regularly (at least annually or more frequently if necessary).
Beyond the main risks, metformin can occasionally cause other side effects. Moderate (rare 1–10%) side effects include headache, dizziness, rash, decreased vitamin B12, weakness, chest discomfort, palpitations, and severe (very rare) side effects include lactic acidosis and megaloblastic anemia.
A metallic taste in the mouth is another possible side effect. Some people report muscle pain or weakness, though these are less common. Most of these effects are temporary and resolve as your body adjusts to the medication.
Metformin is not appropriate for everyone. Your healthcare provider may recommend against it or suggest a lower dose if you have:
Additionally, if you are older (generally over 65), your provider may use a lower dose or monitor you more closely, as aging changes how the body handles metformin.
The best way to minimize the risks of metformin is to maintain open, honest communication with your healthcare team. Before starting metformin, discuss your full medical history, including any kidney or liver problems, heart conditions, infections, or past reactions to medications. Describe your lifestyle, including how much alcohol you drink, because alcohol affects how metformin is processed.
If you experience side effects—whether mild stomach upset or unusual symptoms—report them promptly. Your provider can often adjust your dose, switch formulations, time your doses differently, or recommend strategies to ease symptoms. Regular blood tests allow your doctor to monitor your kidney function, vitamin B12 levels, and blood sugar control, catching any problems early.
Metformin remains a proven, valuable tool for managing blood sugar and reducing the risk of serious diabetes complications. While risks do exist, understanding them and working closely with your healthcare provider helps ensure that the benefits outweigh the drawbacks for your individual situation. Always prioritize open dialogue with your doctor and do not hesitate to ask questions about your medication and your health.